EGFR and neoplasm: By blocking EGFR activation and its downstream signaling, such as the PI3K-AKT and RAS-MAPK pathways, these anti-EGFR agents enhance the cytotoxic effect of ionizing radiation by inducing cell cycle arrest and apoptosis and inhibiting cell proliferation, metastasis and tumor angiogenesis [4], [5].